Yves Heremans

4PUBLICATIONS
54CO-AUTHORS
Molecular targetsElectrochemical energy storage and conversionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 18, 2026
GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection.

|Jan 15, 2026
Transient ER stress cell-autonomously promotes beta cell cycling in mice.

Stephanie Bourgeois, Annelore Van Mulders, Yves Heremans

|Sep 17, 2025
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.

Sana M Arnouk, Daliya Kancheva, Helena Van Damme

|Jul 12, 2025
Verapamil and low-dose anti-mouse thymocyte globulin combination therapy stably reverses recent-onset type 1 diabetes in NOD mice by acting on the beta cell and immune axes.

Laure Degroote, Pieter-Jan Martens, Marijke Viaene

Pageof 1

Frequent Collaborators

3 joint publications

Laure Degroote

3 joint publications

Nico De Leu

3 joint publications

Willem Staels

2 joint publications

Chantal Mathieu